Innate Pharma S.A. - American Depositary Shares (NQ:IPHA)

1.810 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EST, Nov 24, 2025 Add to My Watchlist

Price and Volume

Volume	0
Open	1.810
Bid (Size)	1.840 (26,800)
Ask (Size)	1.930 (1,500)
Prev. Close	1.810
Today's Range	1.810 - 1.810
52wk Range	1.410 - 3.511
Shares Outstanding	78,986,490
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Innate Pharma to Present at Jefferies Global Healthcare Conference

November 17, 2025

From Innate Pharma SA

Via Business Wire

Innate Pharma Reports Third Quarter 2025 Business Update and Financial Results

November 13, 2025

From Innate Pharma SA

Via Business Wire

Performance

YTD	-3.2%	-3.2%
1 Month	-23.9%	-23.9%
3 Month	-19.2%	-19.2%
6 Month	-16.2%	-16.2%
1 Year	+24.8%	+24.8%

More News

Get insights into the top gainers and losers of Tuesday's pre-market session. ↗

November 11, 2025

Via Chartmill

IPHA Stock Soars Pre-Market After FDA Clears Late-Stage Trial For Lacutamab In Rare Skin Cancers ↗

November 10, 2025

Via Stocktwits

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

November 11, 2025

Via Benzinga

Why Rocket Lab Shares Are Trading Higher By Over 9%; Here Are 20 Stocks Moving Premarket ↗

November 11, 2025

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

November 10, 2025

Via Benzinga

Innate Pharma Announces FDA Clearance to Proceed With TELLOMAK 3, a Confirmatory Phase 3 Trial of Lacutamab in CTCL

November 10, 2025

From Innate Pharma SA

Via Business Wire

Innate Pharma Announces Conference Call and Webcast for Third Quarter 2025 Results and Business Updates

November 05, 2025

From Innate Pharma SA

Via Business Wire

This Edwards Lifesciences Analyst Turns Bullish; Here Are Top 4 Upgrades For Wednesday ↗

October 29, 2025

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

October 14, 2025

Via Benzinga

Innate Pharma to Host Analyst and Investor Event on Lacutamab on October 28, 2025

October 14, 2025

From Innate Pharma SA

Via Business Wire

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

September 30, 2025

Via Benzinga

This Progressive Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Thursday ↗

September 18, 2025

Via Benzinga

Alphabet To Rally More Than 14%? Here Are 10 Top Analyst Forecasts For Thursday ↗

September 18, 2025

Via Benzinga

Earnings Scheduled For September 17, 2025 ↗

September 17, 2025

Via Benzinga

Innate Pharma Reports First Half 2025 Business Update and Financial Results

September 17, 2025

From Innate Pharma SA

Via Business Wire

Innate Pharma Announces Its Participation in the 25th Edition of the European Midcap Event

September 15, 2025

From Innate Pharma SA

Via Business Wire

Innate Pharma Announces Conference Call and Webcast for First Half 2025 Financial Results and Business Update

September 10, 2025

From Innate Pharma SA

Via Business Wire

Number of Shares and Voting Rights of Innate Pharma as of September 1, 2025

September 02, 2025

From Innate Pharma SA

Via Business Wire

Number of Shares and Voting Rights of Innate Pharma as of August 1, 2025

August 04, 2025

From Innate Pharma SA

Via Business Wire

Innate Pharma Announces Its Participation in the BTIG Virtual Biotechnology Conference

July 29, 2025

From Innate Pharma SA

Via Business Wire

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

July 28, 2025

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

July 18, 2025

Via Benzinga

Number of Shares and Voting Rights of Innate Pharma as of July 3, 2025

July 04, 2025

From Innate Pharma SA

Via Business Wire

Frequently Asked Questions

Is Innate Pharma S.A. - American Depositary Shares publicly traded?

Yes, Innate Pharma S.A. - American Depositary Shares is publicly traded.

What exchange does Innate Pharma S.A. - American Depositary Shares trade on?

Innate Pharma S.A. - American Depositary Shares trades on the Nasdaq Stock Market

What is the ticker symbol for Innate Pharma S.A. - American Depositary Shares?

The ticker symbol for Innate Pharma S.A. - American Depositary Shares is IPHA on the Nasdaq Stock Market

What is the current price of Innate Pharma S.A. - American Depositary Shares?

The current price of Innate Pharma S.A. - American Depositary Shares is 1.810

When was Innate Pharma S.A. - American Depositary Shares last traded?

The last trade of Innate Pharma S.A. - American Depositary Shares was at 11/24/25 04:00 PM ET

What is the market capitalization of Innate Pharma S.A. - American Depositary Shares?

The market capitalization of Innate Pharma S.A. - American Depositary Shares is 142.97M

How many shares of Innate Pharma S.A. - American Depositary Shares are outstanding?

Innate Pharma S.A. - American Depositary Shares has 143M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.